On-demand webinar
HLA loss mediated immune escape after HSCT: From biology to NGS-based detection
Relapse after allogeneic hematopoietic stem cell transplantation (HSCT) remains a major clinical challenge. Studies show that approximately 30–40% of post-transplant relapses involve HLA loss, particularly in haploidentical transplants and 5-10% in mismatched unrelated donor (MMUD) settings. Understanding and detecting this immune escape mechanism is becoming increasingly important in post-transplant monitoring and translational research. In this webinar, we’ll introduce Devyser HLA Loss, an NGS solution designed to support researchers and laboratories studying post-transplant relapse pathways.
Why watch?
- Biological and genomic basis of HLA loss
- NGS-based detection with Devyser HLA Loss, a simple and rapid workflow
- Dedicated software - Advyser HLA Loss
This session is intended for laboratories and researchers working with HSCT monitoring, NGS-based chimerism analysis, and immune escape mechanisms.
Latest from the Devyser blog
View all
Devyser launches a new updated NGS assay to simplify thalassemia testing
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Read More
Devyser Thalassemia achieves 99.9% sensitivity: Insights from a recent study
Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...
Read More
New insights into thalassemia: Latest studies using Devyser Thalassemia for NGS testing
Read More